Newbury Pharmaceuticals AB (NEWBRY) — Cash Flow Quality Index

Latest as of August 2024: 0.06x

Newbury Pharmaceuticals AB (NEWBRY) has a Cash Flow Quality Index of 0.06x as of August 2024. Operating cash flow of Skr130.00K is below net income of Skr2.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Newbury Pharmaceuticals AB (NEWBRY) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

0.06x

Operating CF / Net Income

Operating Cash Flow

Skr130.00K

SEK

Net Income

Skr2.35 Million

SEK

Data as of

Aug 2024

Most recent filing

Annual Cash Flow Quality Index for Newbury Pharmaceuticals AB (None–None)

Year-by-year earnings quality comparison for Newbury Pharmaceuticals AB. For live market cap and the full company financial profile, see Newbury Pharmaceuticals AB (NEWBRY) total market value.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.